Elizabeth P Henske Selected Research

Tuberous Sclerosis (Bourneville's Disease)

1/2022	ETV2 regulates PARP-1 binding protein to induce ER stress-mediated death in tuberin-deficient cells.
1/2022	Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.
12/2021	TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism.
10/2021	Renal Cell Carcinoma in Tuberous Sclerosis Complex.
1/2021	TSC2 Interacts with HDLBP/Vigilin and Regulates Stress Granule Formation.
1/2021	Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex.
1/2021	Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex.
1/2021	The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back.
1/2021	MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61.
1/2021	Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth P Henske Research Topics

Disease

58	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 03/2002
46	Neoplasms (Cancer) 01/2022 - 03/2002
43	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2022 - 12/2002
20	Angiomyolipoma 10/2021 - 03/2002
12	Renal Cell Carcinoma (Grawitz Tumor) 10/2021 - 01/2007
10	Lung Diseases (Lung Disease) 01/2022 - 11/2012
9	Carcinogenesis 01/2021 - 01/2012
8	Cysts 10/2021 - 01/2009
6	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2005
3	Disease Progression 01/2022 - 01/2018
3	Carcinoma (Carcinomatosis) 12/2019 - 01/2007
3	Seizures (Absence Seizure) 11/2018 - 12/2002
3	Pneumothorax 01/2018 - 05/2017
2	Kidney Neoplasms (Kidney Cancer) 10/2021 - 01/2018
2	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 01/2016
2	Lung Injury 01/2021 - 11/2018
2	Autistic Disorder (Autism) 11/2018 - 12/2002
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2018 - 02/2014
2	Hyperplasia 01/2018 - 01/2012
2	Hypoxia (Hypoxemia) 03/2016 - 12/2009
2	Perivascular Epithelioid Cell Neoplasms 01/2016 - 10/2014
1	Shock 01/2021
1	Surfactant Dysfunction 01/2021
1	COVID-19 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Renal Insufficiency (Renal Failure) 01/2021
1	Ventilator-Induced Lung Injury 01/2021
1	Lymphatic Abnormalities 12/2019
1	Adenoma (Adenomas) 01/2019
1	Rheumatoid Arthritis 11/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2018

Drug/Important Bio-Agent (IBA)

51	trans-sodium crocetinate (crocetin)IBA 12/2021 - 12/2002
32	lipoarabinomannan (LAM)IBA 01/2022 - 02/2009
28	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 01/2012
18	Sirolimus (Rapamycin)FDA Link 01/2021 - 06/2006
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
10	TOR Serine-Threonine KinasesIBA 12/2019 - 04/2003
8	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2004
5	MTOR InhibitorsIBA 01/2020 - 06/2006
5	Phosphotransferases (Kinase)IBA 03/2016 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	Glutathione (Reduced Glutathione)IBA 12/2020 - 01/2017
4	Tuberous Sclerosis Complex 2 ProteinIBA 02/2009 - 12/2002
3	Estrogens (Estrogen)FDA Link 11/2016 - 02/2009
3	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 06/2006
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2021
2	NucleotidesIBA 01/2020 - 11/2017
2	MicroRNAs (MicroRNA)IBA 12/2019 - 01/2013
2	NestinIBA 01/2019 - 11/2017
2	Vascular Endothelial Growth Factor DIBA 01/2018 - 01/2017
2	TransferasesIBA 01/2018 - 04/2008
2	Ribosomal Protein S6IBA 04/2008 - 06/2006
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 06/2006 - 04/2003
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Lipid NanoparticlesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	arseniteIBA 01/2021
1	AcidsIBA 01/2021
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2021
1	ChromatinIBA 01/2021
1	ElectrolytesIBA 01/2021
1	Proton-Translocating ATPases (ATPase, H+)IBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Surface-Active Agents (Surfactants)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	RitanserinIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Microphthalmia-Associated Transcription FactorIBA 01/2021
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2021
1	mizoribineIBA 01/2020
1	CarcinogensIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	EnzymesIBA 01/2020
1	RetinoidsIBA 12/2019
1	AntibodiesIBA 12/2019
1	mouse MIRN29 microRNAIBA 12/2019
1	PolyaminesIBA 12/2019
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 12/2019
1	Programmed Cell Death 1 ReceptorIBA 12/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	vistusertibIBA 01/2019
1	Codon (Codons)IBA 01/2019
1	EndostatinsIBA 01/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Proline (L-Proline)FDA Link 01/2019
1	Vitamin D-Binding ProteinIBA 11/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2018
1	Oxygen (Dioxygen)IBA 01/2018

Therapy/Procedure

11	Therapeutics 01/2022 - 03/2002
2	Immunotherapy 12/2019 - 01/2018
1	Aftercare (After-Treatment) 11/2018